- Duración
- January-December 2020
- Coordinador
- Jordi Vila (ISGlobal) and David Miñana (UB)
- Financiadores
- EIT Health Campus
- Página web
- https://safeinitiative.eu/
The aim of SAFE is to perform a service learning activity in the field of microbiology, particularly on antimicrobial resistance, for the training of Graduate/Master/PhD students who in turn will conduct the training of highschool students supervised by university professors/researchers experts on this area. Trainings will include the isolation of strains and search for antibacterial activity from natural sources (e.g. soil).
Students will also participate in activities organized during Science Festivals and World Antibiotic Awareness Week for the diffusion of the AMR issue towards citizens as well as gamification through Micro-Combat (designed by ISGlobal).
Additionally, one of these activities will be a competition among high school students participating in SAFE. The winners will have the opportunity to do a short internship at Roche Diagnostics enriching their vision through the incorporation of an entrepreneurial perspective in the field of antimicrobial resistance.
Budget
181,573 euros
Nuestro equipo
Coordinator
-
Jordi Vila Research Professor, Director de la Iniciativa de Resistencias Antimicrobianas y del programa de Infecciones Víricas y Bacterianas
ISGlobal team
-
Clara Ballesté Coordinadora de la Iniciativa de Resistencias Antimicrobianas y Asistente de Proyectos de Jordi Vila -
Marina Tarrús Técnica de divulgación científica
Otros proyectos
Ver proyectos pasadosCOMBACTE
Combatiendo la Resistencia Bacteriana en Europa
Evaluación de estrategias para la erradicación de la enfermedad del Pian
Erradicación del Pian
Novel Marine Biomolecules against Biofilm (NoMorFilm)
Application to medical devices
www.nomorfilm.euCOMBACTE-CARE
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
https://www.imi.europa.eu/content/combacte-carePrioritising Antimicrobial Resistance: establishing an interdisciplinary International Research Partnership to tackle an evolving global health threat
An interdisciplinary International Research Partnership to tackle an evolving global health threat
Development of new metal-antibiotics against pathogens causing chronic infections in patients with cystic fibrosis.
New metal-antibiotics for patients with cystic fibrosis
HU-MEN (High frequency Ultrasound-based MENingitis screening)
Non-invasive ultrasound-based screening for meningitis: Proof-of concept in infants
Xpatial-TB
Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique
WHIP3TB
Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals
https://clinicaltrials.gov/ct2/show/NCT02980016New antibacterial agents against 'Acinetobacter baumannii'
Search for new target proteins and use of antibacterial or inhibitory peptides against resistance mechanisms in 'Acinetobacter baumannii'
Desarrollo de nuevos metaloantibióticos frente a patógenos causantes de infecciones crónicas en pacientes con fibrosis quística
VINCI
Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique
INTE-AFRICA
Integrating and decentralizing diabetes and hypertension services in Africa
http://inteafrica.org/AVATAR
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
COVID-PREG
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT)
Estudio piloto para evaluar el potencial de la ivermectina para reducir la transmisión de COVID-19
http://www.saintproject.org